VARIANTYX  POSTS

Where did “Exome Plus” go?

Longtime customers familiar with our Genomic Unity® Exome Plus Analysis may be wondering where did it go? The short answer is that it’s still available. …

Read More

FXN: What you need to know for Friedreich’s ataxia patients

It’s well known that FXN repeat expansions cause Friedreich’s ataxia, but in certain cases, the affected individual is compound heterozygous for an expansion plus another pathogenic variant.

Read More

Is WGS-based testing relevant for patients with suspected mitochondrial disease?

In short, yes! But let’s take a step back and start with what mitochondrial disease is.

Read More

Get to know the genes behind epilepsy

Today we’re taking a look at some important epilepsy-related genes for which testing can be particularly tricky due to their propensity for deletion and/or duplication variants and tandem repeat expansions …

Read More

National kidney month: Literature round up

This year we’re taking a survey of recent literature that’s influencing the way clinicians may approach genetic testing and treatment decisions for patients presenting with symptoms of kidney disorders now and in the future. Read on to learn with us …

Read More

Variantyx Inc.

1671 Worcester Road, Suite 300
Framingham MA 01701 USA

Phone: +1 617-209-2090

  • This site is protected by reCAPTCHA and the Google Privacy and Terms of Service apply